跳至主要内容
临床试验/NL-OMON52151
NL-OMON52151招募中不适用

Blood-brain barrier leakage as a predictive factor for post-stroke epilepsy - BBBinPSE

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 72 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • A SeLECT score 0-9 or a CAVE score 0-4
  • Age of >= 18 years

排除标准

  • Contra-indications for a gadolinium based contrast agent (known allergy or
  • insufficient kidney function determined by an eGFR <= 30 mL/min)
  • Contra-indications for MRI scanning (e.g. metal implants, cardiac pacemaker,
  • claustrophobia, pregnancy)
  • Previous history of epileptic seizures or other cerebral disorders (e.g.
  • neurodegenerative diseases or head/brain tumors)
  • Re-infarction during follow-up
  • Potential epileptogenic co-morbidities (e.g. alcohol or drugs abuse, cerebral
  • venous thrombosis, history of brain surgery)
  • Absence of written informed consent (by a legal representative)

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验